Quick Answer
PALISADE BIO, INC. reported Common Stock Shares Outstanding of 159.44 million shares for the year ending 2025.
- PALISADE BIO, INC. showed an increase of +5,658.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from PALISADE BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), PALISADE BIO, INC.'s Common Stock Shares Outstanding has grown by 240.0%.
- Historical annual values: Fiscal year 2025: 159.44 million shares | Fiscal year 2024: 2.77 million shares | Fiscal year 2023: 618,056 shares | Fiscal year 2022: 2.94 million shares | Fiscal year 2021: 284,780 shares | Fiscal year 2020: 2.77 million shares | Fiscal year 2019: 3.87 million shares | Fiscal year 2018: 910,253 shares | Fiscal year 2017: 15.16 million shares | Fiscal year 2016: 11.03 million shares | Fiscal year 2015: 7.08 million shares | Fiscal year 2014: 87.79 million shares | Fiscal year 2013: 77.89 million shares | Fiscal year 2012: 68.19 million shares | Fiscal year 2011: 48.68 million shares | Fiscal year 2010: 46.90 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: